MedTrace Logo

Shanghai Community Cohort Establishment and Follow-up

NCT04517513 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80000

Last updated 2023-07-11

No results posted yet for this study

Summary

Our objective is to establish a natural population cohort in East China based on the latest scientific researches, preliminary findings of the project team, and a close cooperation model of the Specialist Medical Consortium.

Firstly, we will focus on the information and management status of high-risk, single-patient, and co-occurring patient groups of cardio cerebral diseases such as coronary heart disease and stroke. We plan to integrate the questionnaire data and sample database information into the cardio-cerebral "co-prevention and management" information platform, in order to establish a cardiovascular and cerebrovascular disease management system.

Secondly, we aim to develop a new risk prediction model for heart and brain diseases based on the big data platform, lead the establishment of the "co-prevention and management" innovation management model for cardio cerebral diseases, and explore an integrated and innovative health management model for the prevention and treatment of cardio cerebral diseases for China.

Conditions

Sponsors & Collaborators

  • Jinqiao Community Health Service Center of Pudong new area, Shanghai

    collaborator UNKNOWN

  • Heqing Community Health Service Center of Pudong new area, Shanghai

    collaborator UNKNOWN

  • Weifang Community Health Service Center of Pudong new area, Shanghai

    collaborator UNKNOWN

  • Jinyang Community Health Service Center of Pudong new area, Shanghai

    collaborator UNKNOWN

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Jun Pu, MD,PhD · RenJi Hospital

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-07
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04517513 on ClinicalTrials.gov